Rationale and clinical use of multitargeting anticancer agents-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rationale and clinical use of multitargeting anticancer agents

Published:2013-08 Issue:4 Volume:13 Page:536-542
ISSN:1471-4892
Container-title:Current Opinion in Pharmacology
language:en
Short-container-title:Current Opinion in Pharmacology

Author:

Melisi Davide,Piro Geny,Tamburrino Anna,Carbone Carmine,Tortora Giampaolo

Funder

Associazione Italiana per la Ricerca sul Cancro (AIRC) Start-Up

AIRC

AIRC 5 per mille

PRIN

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference44 articles.

1. Cancer genome landscapes;Vogelstein;Science,2013

2. The genomic landscapes of human breast and colorectal cancers;Wood;Science,2007

3. Comprehensive genomic characterization defines human glioblastoma genes and core pathways;Cancer Genome Atlas Research Network;Nature,2008

4. The landscape of cancer genes and mutational processes in breast cancer;Stephens;Nature,2012

5. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes;Biankin;Nature,2012

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multitarget Pharmacology of Sulfur–Nitrogen Heterocycles: Anticancer and Antioxidant Perspectives;Antioxidants;2024-07-25

2. Exceptional Clinical Response to Alectinib in Pancreatic Acinar Cell Carcinoma With a Novel ALK-KANK4 Gene Fusion;JCO Precision Oncology;2022-05

3. Role of next-generation genomic sequencing in targeted agents repositioning for pancreaticoduodenal cancer patients;Pancreatology;2021-09

4. Design, Synthesis and Anticancer Activity of a New Series of N-aryl-N′-[4-(pyridin-2-ylmethoxy)benzyl]urea Derivatives;Molecules;2021-06-08

5. A phase II trial of the FGFR inhibitor pemigatinib in patients with metastatic esophageal–gastric junction/gastric cancer trastuzumab resistant: the FiGhTeR trial;Therapeutic Advances in Medical Oncology;2020-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3